{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:08:37Z","timestamp":1784218117675,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajoc.2026.102588","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:32:15Z","timestamp":1777073535000},"page":"102588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mast cell activation syndrome-related unusual periocular inflammation associated with mydriatic eyedrops during cataract surgery"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-8567","authenticated-orcid":false,"given":"Anny M.S.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishah","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"LiVecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade Gieseke","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajoc.2026.102588_bib1","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1016\/j.jaip.2021.06.011","article-title":"Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review","volume":"9","author":"G\u00fclen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.ajoc.2026.102588_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.amjms.2016.12.013","article-title":"Characterization of mast cell activation syndrome","volume":"353","author":"Afrin","year":"2017","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.ajoc.2026.102588_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.annder.2024.103328","article-title":"Ocular and palpebral manifestations of mastocytosis: a prospective single-center study","volume":"152","author":"Guerin","year":"2025","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.ajoc.2026.102588_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cod.14552","article-title":"Contact allergy to topical ophthalmic medications: a retrospective single-centre study of three decades","volume":"91","author":"Svendsen","year":"2024","journal-title":"Contact Dermat"},{"issue":"7","key":"10.1016\/j.ajoc.2026.102588_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000524532","article-title":"Mast cell activation syndromes: collegium internationale allergologicum update 2022","volume":"183","author":"Valent","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.ajoc.2026.102588_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000501079","article-title":"Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome","volume":"180","author":"Valent","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"10.1016\/j.ajoc.2026.102588_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13071116","article-title":"Mast cell activation syndrome Update-A dermatological perspective","volume":"13","author":"Mihele","year":"2023","journal-title":"J Personalized Med"},{"issue":"6","key":"10.1016\/j.ajoc.2026.102588_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjms.2019.03.005","article-title":"Recognition and management of medication excipient reactivity in patients with mast cell activation syndrome","volume":"357","author":"Schofield","year":"2019","journal-title":"Am J Med Sci"},{"issue":"7","key":"10.1016\/j.ajoc.2026.102588_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00210-016-1247-1","article-title":"Pharmacological treatment options for mast cell activation disease","volume":"389","author":"Molderings","year":"2016","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"10.1016\/j.ajoc.2026.102588_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/07853890.2016.1161231","article-title":"Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options","volume":"48","author":"Afrin","year":"2016","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.ajoc.2026.102588_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11882-024-01183-5","article-title":"Mast cells and mas-related G protein-coupled receptor X2: itching for novel pathophysiological insights to clinical relevance","volume":"25","author":"Castells","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.ajoc.2026.102588_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s40521-023-00349-2","article-title":"Triggers of anaphylaxis in mastocytosis patients: evidence of the current drug-avoidance recommendation","volume":"10","author":"Rama","year":"2023","journal-title":"Curr Treat Options Allergy"},{"issue":"4","key":"10.1016\/j.ajoc.2026.102588_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/PL00005179","article-title":"The M2 muscarinic receptor antagonist methoctramine activates mast cells via pertussis toxin-sensitive G proteins","volume":"357","author":"Chahdi","year":"1998","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.ajoc.2026.102588_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002266","article-title":"Case-control cohort study of patients' perceptions of disability in mastocytosis","volume":"3","author":"Hermine","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajoc.2026.102588_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0536.1998.tb05682.x","article-title":"Reliability of diagnostic tests for contact allergy to mydriatic eyedrops","volume":"38","author":"Villarreal","year":"1998","journal-title":"Contact Dermat"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:47:13Z","timestamp":1784216833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993626000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":15,"alternative-id":["S2451993626000769"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102588","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cell activation syndrome-related unusual periocular inflammation associated with mydriatic eyedrops during cataract surgery","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102588"}}